Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2011; 136(11): 525-532
DOI: 10.1055/s-0031-1274537
DOI: 10.1055/s-0031-1274537
CME | Review article
Endokrinologie
© Georg Thieme Verlag KG Stuttgart · New York
Risikostratifizierte Therapie der Osteoporose
Risk adapted treatment of osteoporosisFurther Information
Publication History
eingereicht: 21.11.2010
akzeptiert: 17.2.2011
Publication Date:
08 March 2011 (online)
Schlüsselwörter
Osteoporose - Frakturen - Kalzium - Vitamin D - Knochendichte
Keywords
osteoporosis - fractures - calcium - vitamin D - bone mineral density
Literatur
- 1 Bauer D C, Ettinger B, Nevitt M C. et al . Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med. 2001; 134 561-568
- 2 Bianchi G, Sambrook P. Oral nitrogen-containing bisphosphonates: a systematic review of randomized clinical trials and vertebral fractures. Curr Med Res Opin. 2008; 24 2669-2677
- 3 Bolland M J, Barber P A, Doughty R N. et al . Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ. 2008; 336 262-266
- 4 Curtis J R, Westfall A O, Cheng H. et al . Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday. Osteoporos Int. 2008; 19 1613-1620
- 5 DVO-Leitlinie 2009 zur Prophylaxe, Diagnostik und Therapie der Osteoporose bei Erwachsenen. Osteologie. 2009; 18 304-328 http://www.dv-osteologie.org/dvo_leitlinien/dvo-leitlinie-2009
- 6 Gallagher A, Rietbrock S, Olson M. et al . Fracture outcomes related to persistence and compliance with oral bisphosphonates. J Bone Miner Res. 2008; 23 1569-1575
- 7 Fournier M R, Targownik L E, Leslie W D. Proton pump inhibitors, osteoporosis, and osteoporosis-related fractures. Maturitas. 2009; 64 9-13
- 8 Holick M F, Chen T C. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008; 87 1080S-1086S
- 9 Ito Z, Harada A, Matsui Y. et al . Can you diagnose for vertebral fracture correctly by plain X-ray?. Osteoporos Int. 2006; 17 1584-1591
- 10 McCloskey E V, Johansson H, Oden A. et al . Ten-year fracture probability identifies women who will benefit from clodronate therapy-additional results from a double-blind, placebo-controlled randomised study. Osteoporos Int. 2009; 20 811-817
- 11 Pfeilschifter J. Schmerztherapie bei Osteoporose. Allgemeinarzt. 2007; 19 32-37
- 12 Saag K G, Shane E, Boonen S. et al . Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med. 2007; 357 2028-2039
- 13 Seeman E. Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?. Bone. 2007; 41 308-317
- 14 Steingrimsdottir L, Gunnarsson O, Indridason O S. et al . Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA. 2005; 294 2336-2341
- 15 Tervo T, Nordström P, Neovius M. et al . Constant Adaptation of Bone to Current Physical Activity Level in Men: A 12-Year Longitudinal Study. J Clin Endocrinol Metab. 2008; 93 4873-4879
- 16 van Brussel M S, Lems W F. Clinical relevance of diagnosing vertebral fractures by vertebral fracture assessment. Curr Osteoporos Rep. 2009; 7 103-106
Prof. Dr. med. Johannes Pfeilschifter
Alfried Krupp Krankenhaus – Steele
Klinik
für Innere Medizin III
Hellweg 100
45276
Essen
Phone: 0201/805-1847
Fax: 0201/805-2185
Email: Johannes.Pfeilschifter@krupp-krankenhaus.de